Swissmedic

Changes to the guidance document RMP ICH E2E information submission HMP

Swissmedic updates guidance on risk management plan information submission under ICH E2E for human medicinal products.

High obligation Framework Pharmaceuticals Switzerland Pharmacovigilance

01.08.2026

Dates and deadlines

Applies from

2026-08-01

Read the official source ↗

Published by Swissmedic. HealthSignal links to the original document; the summary above is extracted from the source text.